Coronavirus: Screening
(asked on 14th April 2022) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 April 2022 to Question 145835 on Coronavirus: Screening, what criteria are used to determine commercial sensitivity; and what his timescale is for publishing the number of lateral flow device tests issued to the public or used in healthcare settings since March 2020.
The specific expenditure on lateral flow device (LFD) tests is commercially sensitive as it could prejudice the Department’s future commercial relations with suppliers if this information were to be disclosed. On 14 April 2022, we published data on the number of LFD tests dispatched from September 2020 to February 2022, by use case. This information is available at the following link:
Prior to September 2020 LFD tests were not in use.